Welcome - Register - Login - Help/FAQ - 0 items

Search Enter keywords, a title or a report id number below. In All Categories --------------------- Telecom & Computing Business & Finance Mfg & Construction Pharma & Healthcare Consumer & Retail Gov & Public Sector Energy & Transport Country Reports Company Reports --------------------- Transcripts Advanced      Select a currency for use throughout the site Australia Dollars Canada Dollars Euro Japan Yen Sweden Kroner Switzerland Francs UK Pounds US Dollars Search Results Your Search for 'Actar AB' returned 18 results - Page 1 of 1   Sort by    Date Published ASC Date Published DESC Report Price ASC Report Price DESC Rank ASC Rank DESC   Sorted by Rank Top-Bottom Actar AB-Detailed Product Pipeline   Life Science Analytics, March 2011, Pages: 17 Actar AB-Detailed Product Pipeline provides up to date insight into company’s business description, product information, pipeline details including both summary information and detailed individual Actar AB - Product Pipeline Review - Q4 2010   GlobalData, Nov 2010, Pages: 21 Actar AB – Product Pipeline Review – Q4 2010 Summary Global Market Direct’s pharmaceuticals report, “Actar AB - Product Pipeline Review - Q4 2010” provides data on the company Actar AB - Product Pipeline Review - Q4 2010   Global Markets Direct, Nov 2010, Pages: 21 Actar AB – Product Pipeline Review – Q4 2010 Summary Global Market Direct’s pharmaceuticals report, “Actar AB - Product Pipeline Review - Q4 2010” provides data on the company Actar AB-Therapeutic Competitors Report   Life Science Analytics, March 2011, Pages: 50 Actar AB-Therapeutic Competitors Report Report includes a business summary, tabular representation of the number and percentage of products in each therapeutic indication, all company products Burkitt Lymphoma - Pipeline Review, Q4 2010   Global Markets Direct, Dec 2010, Pages: 26 Involved in Burkitt Lymphoma Therapeutics Development Genmab A/S Actar AB ViroStatics, srl Universities/Institutes Involved in Burkitt Lymphoma Therapeutics Development Burkitt Lymphoma Patent Analysis of Adenosine A2A Receptor Agonists   Chemvalet Inc., July 2005, Pages: 152 Section B - Company Patent Profiles 23 Company Patent Profiles (not listed here) Section C - Unassigned Patent Applications Section D - Universities/Organizations/Government - Actar AB - Adenosine Burkitt Lymphoma - Pipeline Review, Q2 2011   Global Markets Direct, April 2011, Pages: 94 Development Genmab A/S Actar AB ViroStatics, srl Burkitt Lymphoma - Therapeutics Assessment Assessment by Monotherapy Products Assessment by Combination Products Assessment by Route Cervical Cancer - Pipeline Review, Q1 2011   Global Markets Direct, Feb 2011, Pages: 119 . 3SBio Inc. ARQULE, INC Dendreon Corporation ProMetic Life Sciences Inc. LG Life Sciences, Ltd Actar AB Dafra Pharma International Ltd. ApoImmune, Inc. PDS Biotechnology Ovarian Cancer - Pipeline Review, Q1 2011   Global Markets Direct, Jan 2011, Pages: 286 Pharmaceutical AB Algeta ASA Protox Therapeutics Inc. Rexahn Pharmaceuticals, Inc. Baylor College of Medicine Oryzon Debiopharm Group Actar AB Supratek Pharma Inc. GANYMED Prostate Cancer - Pipeline Review, Q1 2011   Global Markets Direct, Feb 2011, Pages: 321 Ltd Actar AB Biotecnol SA Camurus AB Immupharma Plc Actis Biologics, Inc Nerviano Medical Sciences S.r.l. Med Discovery SA Glycotope GmbH ERYtech Pharma Pro-Cure Small-Cell Lung Cancer - Pipeline Review, Q1 2011   Global Markets Direct, Jan 2011, Pages: 138 Pharmaceuticals, Inc. TapImmune Inc. Synta Pharmaceuticals Corp. Simcere Pharmaceutical Group Actar AB Supratek Pharma Inc. Celator Pharmaceuticals, Inc. Neotropix, Inc. Proacta, Inc. Mol Colon Cancers - Pipeline Review, Q1 2011   Global Markets Direct, Feb 2011, Pages: 152 Corporation Prima BioMed Limited CrystalGenomics, Inc. BioAlliance Pharma SA Sareum Holdings plc Rexahn Pharmaceuticals, Inc. Debiopharm Group Actar AB Immupharma Plc Multimmune Gmb Lymphoma - Pipeline Review, Q1 2011   Global Markets Direct, Jan 2011, Pages: 278 Pharmaceuticals Corp. CrystalGenomics, Inc. Protox Therapeutics Inc. Piramal Life Sciences Limited Baylor College of Medicine Debiopharm Group Actar AB PanGenetics B.V. Multimmune Gmb Head And Neck Cancer - Pipeline Review, Q1 2011   Global Markets Direct, Feb 2011, Pages: 241 of Medicine Wilex AG Actar AB Multimmune GmbH Glycotope GmbH Matrix Pharmaceutical Research Hawthorn Pharmaceuticals, Inc. PDS Biotechnology Corporation Azaya Therapeutics, Inc Cervical Cancer - Pipeline Review, Q4 2010   Global Markets Direct, Dec 2010, Pages: 126 Gynecologic Oncology Group Dendreon Corporation ProMetic Life Sciences Inc. Actar AB Dafra Pharma International Ltd. PDS Biotechnology Corporation ImmunoVaccine Technologies Inc. BT PHARMA Head And Neck Cancer - Pipeline Review, Q4 2010   Global Markets Direct, Dec 2010, Pages: 235 . James Cancer Hospital & Richard J. Solove Research Institute Wilex AG Actar AB Memorial Sloan Kettering Cancer Center Multimmune GmbH Glycotope GmbH Matrix Pharmaceutical Prostate Cancer - Pipeline Review, Q4 2010   Global Markets Direct, Dec 2010, Pages: 321 Pharmaceuticals Plc Eisai Inc. Emiliem, Inc. Affitech A/S Debiopharm Group Colby Pharmaceutical Company Chipscreen Biosciences Ltd Actar AB Immupharma Plc Nerviano Medical Sciences S Breast Cancer - Pipeline Review, Q3 2011   Global Markets Direct, July 2011, Pages: 940 , 2011 Affitech A/S, 2011 Debiopharm Group, 2011 Wilex AG, 2011 Chipscreen Biosciences Ltd, 2011 INSYS Therapeutics, Inc., 2011 Actar AB, 2011 Supratek Pharma Inc., 2011 Meabco Results:  First -   Prev -   1 -   Next -   Last

		For enquiries please call us on:   +353-1-415-1241 (GMT Office Hours)   1-800-526-8630 (US/Canada Toll Free)   1-917-300-0470 (EST Office Hours)

All rights reserved. © Copyright 2012 Research and Markets3    Terms and conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster Affiliate Network